CSNK2A1 Foundation Funds Innovative Research in the Chow Lab to Expedite Potential Treatments for OCNDS
“We are excited to provide Dr. Chow with the grant award. His innovative approach using the Drosophila model and repurposing existing FDA-approved drugs holds tremendous promise.” ” — Dr. Gabrielle Rushing, the CSNK2A1 Foundation Science Program Director SAN FRANCISCO, CA, USA, December 29, 2023 /EINPresswire.com/ — CSNK2A1 Foundation, a leading rare disease organization, is thrilled…
